Takeda overhauls management under Weber's leadership
This article was originally published in Scrip
Executive Summary
New senior management changes at Takeda bear the globalizing hallmark of Christophe Weber, who became chief operating officer in April and president in June, and who is expected to take the helm as CEO in the not too distant future. On 16 September Takeda announced a major organizational overhaul, establishing five regional business units, separating the Japan pharma business from the North Asian unit, and merging North Asian into Emerging Market. The goal is "to establish an operation system meeting patients' and medical professionals' needs."